FilingSEC EDGAR8-K
bioAffinity Technologies Receives Notice of Allowance for CyPath® Lung Patent from Japan Patent Office
· SEC accepted
StageNotice of Allowance
Filing content
The company received a Notice of Allowance from the Japan Patent Office for its CyPath® Lung early lung cancer detection method, with the patent expected to issue upon payment of fees.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…